Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia

References

• Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357–368.
   PubMed Web of Science ®Google Scholar
• Jobe A. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641–643.
   PubMed Web of Science ®Google Scholar
• Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999;103: 759–765.
   PubMed Web of Science ®Google Scholar
• Panickar J, Scholefield H, Kumar Y, Pilling DW, Subhedar NV. Atypical chronic lung disease in preterm infants. J Perinat Med 2004;32:162–167.
   PubMed Web of Science ®Google Scholar
• Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605–610.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825–830.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773–779.
   PubMed Web of Science ®Google Scholar
• Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002;140:171–176.
   PubMed Web of Science ®Google Scholar
• Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr 2006;95:38–43.
   PubMed Web of Science ®Google Scholar
• Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, . Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39: 966–975.
   PubMed Web of Science ®Google Scholar
• Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, . Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55:1009–1017.
   PubMed Web of Science ®Google Scholar
• Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29–38.
   PubMedGoogle Scholar
• Kim DH, Kim HS, Shim SY, Lee JA, Choi CW, Kim EK, . Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia. Neonatology 2008;93:223–229.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Chronic lung disease: the role of oxidative stress. Biol Neonate 1998;74(Suppl 1):21–28.
   PubMedGoogle Scholar
• Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39–49.
   PubMedGoogle Scholar
• Choi CW, Kim BI, Hong JS, Kim EK, Kim HS, Choi JH. Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 2009;65:323–327.
   PubMed Web of Science ®Google Scholar
• Evans M, Palta M, Sadek M, Weinstein MR, Peters ME. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol 1998;148:460–466.
   PubMed Web of Science ®Google Scholar
• Westcott JY, Smith HR, Wenzel SE, Larsen GL, Thomas RB, Felsien D, Voelkel NF. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am Rev Respir Dis 1991;143:1322–1328.
   PubMed Web of Science ®Google Scholar
• Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339: 1–9.
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–1729.
   PubMedGoogle Scholar
• Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982;145:1–8
   PubMed Web of Science ®Google Scholar
• Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev 1988;9: 219–226.
   PubMedGoogle Scholar
• Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventicular hemorrhage of the premature infant. Neurology of the Newborn. 5th Philadelphia, PA: Saunders; 2008. 517–588.
   Google Scholar
• Ogihara T, Kim H-S, Hirano K, Imanishi M, Ogihara H, Tamai H, . Oxydation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol Neonate 1998;73:24–33.
   PubMedGoogle Scholar
• Subramaniam M, Bausch C, Twomey A, Andreeva S, Yoder BA, Chang L, . Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007;176:902–912.
   PubMed Web of Science ®Google Scholar
• Reuter SD, O'Donovan DJ, Hegemier SE, Smith EO, Heird WC, Fernandes CJ. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia. J Perinatol 2007;27:303–306.
   PubMed Web of Science ®Google Scholar
• Chessex P, Watson C, Kaczala GW, Rouleau T, Lavoie ME, Friel J, Lavoie JC. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med 2010;49:1380–1386.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Hirano K, Morinobu T, Kim HS, Ogawa S, Hiroi M, . Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 2006;60:613–618.
   PubMed Web of Science ®Google Scholar
• Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, Endo F. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002;36:189–193.
   PubMed Web of Science ®Google Scholar
• Ates O, Alp HH, Caner I, Yildirim A, Tastekin A, Kocer I, Baykal O. Oxidative DNA damage in retinopathy of prematurity. Eur J Ophthalmol 2009;19:80–85.
   PubMed Web of Science ®Google Scholar
• Walsh SW. Evidence for 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene C4(LTC4) in the onset of labor. Ann N Y Acad Sci 1991;622:341–354.
   PubMedGoogle Scholar
• Halvorsen T, Skadberg BT, Eide GE, Roksund O, Aksnes L, Oymar K. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol 2005;16:487–494.
   PubMed Web of Science ®Google Scholar
• Davidson D, Drafta D, Wilkens BA. Elevated urinary leukotriene E4 in chronic lung disease of extreme prematurity. Am J Respir Crit Care Med 1995;151:841–845.
   PubMed Web of Science ®Google Scholar
• Sheikh S, Null D, Gentile D, Bimle C, Skoner D, McCoy K, Guthrie R. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Chest 2001;119:1749–1754.
   PubMed Web of Science ®Google Scholar